"For women who smoke in pregnancy, few evidence-based treatments are available to help them quit. One of our priorities in the SSW will be developing effective smoking cessation interventions that are accessible to these women."
Factors affecting relapse to substance use among the dually diagnosed; affect regulation treatments for substance use; smoking interventions among pregnant women; and learning factors in substance use.
Dr. Bradizza’s current research includes projects that span alcohol, tobacco and non-combustible nicotine delivery products. She is currently involved as a multiple principal investigator on a study testing an affect regulation intervention for alcohol use disorders, and has completed a treatment development study of an affect regulation intervention for pregnant smokers. In addition, she is collaborating on two studies investigating the impact of pretreatment change on treatment outcomes and a tailored treatment approach that is responsive to pretreatment change among alcohol dependent individuals. She also is collaborating on a laboratory study investigating the pharmacokinetics of E-cigarettes products among tobacco-using smokers.
Dr. Bradizza maintains a strong interest in developing innovative and efficacious interventions for underserved individuals who struggle with addictions including tobacco and alcohol.